Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining

Abstract

Ex vivo ELISPOT and multimer staining are well-established tests for the assessment of antigen-specific T cells. Many laboratories are now using a period of in vitro stimulation (IVS) to enhance detection. Here, we report the findings of a multi-centre panel organised by the Association for Cancer Immunotherapy Immunoguiding Program to investigate the impact of IVS protocols on the detection of antigen-specific T cells of varying ex vivo frequency. Five centres performed ELISPOT and multimer staining on centrally prepared PBMCs from 3 donors, both ex vivo and following IVS. A harmonised IVS protocol was designed based on the best-performing protocol(s), which was then evaluated in a second phase on 2 donors by 6 centres. All centres were able to reliably detect antigen-specific T cells of high/intermediate frequency both ex vivo (Phase I) and post-IVS (Phase I and II). The highest frequencies of antigen-specific T cells ex vivo were mirrored in the frequencies following IVS and in the detection rates. However, antigen-specific T cells of a low/undetectable frequency ex vivo were not reproducibly detected post-IVS. Harmonisation of the IVS protocol reduced the inter-laboratory variation observed for ELISPOT and multimer analyses by approximately 20 %. We further demonstrate that results from ELISPOT and multimer staining correlated after (P < 0.0001 and R2 = 0.5113), but not before IVS. In summary, IVS was shown to be a reproducible method that benefitted from method harmonisation.Electronic supplementary materialThe online version of this article (doi:10.1007/s00262-014-1593-0) contains supplementary material, which is available to authorized users.

Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis

“…Importantly, our observed results fit into recently published observations addressing the benefits and outcomes of extended resting of thawed PBMC on their functionality [ 13 , 18 , 32 ], as demonstrated with different experimental approaches. ELISPOT is one of the most commonly used tests in the immune monitoring setting.…”

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

“…We observed that the clone of anti-CD124 antibody and the composition of the lineage cocktail significantly influenced the quantification of CD124 + MDSCs and immature MDSCs, respectively. The issue of the heterogeneity of reagents was also present in previous proficiency panels, in which a partial standardization of reagents had been suggested [ 25 ], especially for culturing of PBMCs intended to be used for functional T cell assays [ 23 , 26 , 27 ]. The MDSC proficiency panel introduced the use of a DCM, and, as expected, we observed that the percentages of several MDSC subsets, and in particular of granulocytic ones, were significantly reduced by dead-cell exclusion.…”

Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma

“…However, evaluation of the cellular immune responses is necessary to compare the ability of the 2 different immunostimulatory sequences to induce the activation of T-helper cells, as measured by the production of IFN-g and capture using ELISPOT assay. 42 …”